These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer. Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750 [TBL] [Abstract][Full Text] [Related]
6. Examining plasma microRNA markers for colorectal cancer at different stages. Sun Y; Liu Y; Cogdell D; Calin GA; Sun B; Kopetz S; Hamilton SR; Zhang W Oncotarget; 2016 Mar; 7(10):11434-49. PubMed ID: 26863633 [TBL] [Abstract][Full Text] [Related]
7. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer. Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555 [TBL] [Abstract][Full Text] [Related]
8. Validation of miR-1228-3p as Housekeeping for MicroRNA Analysis in Liquid Biopsies from Colorectal Cancer Patients. Duran-Sanchon S; Vila-Navarro E; Marcuello M; Lozano JJ; Muñoz J; Cubiella J; Diez MS; Bujanda L; Lanas A; Jover R; Hernández V; Quintero E; Herreros-Villanueva M; Martín AC; Pérez-Palacios R; Arroyo R; Castells A; Gironella M Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31877644 [TBL] [Abstract][Full Text] [Related]
9. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer. Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y Oncology; 2017; 92(6):360-370. PubMed ID: 28376502 [TBL] [Abstract][Full Text] [Related]
10. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209 [TBL] [Abstract][Full Text] [Related]
11. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223 [TBL] [Abstract][Full Text] [Related]
12. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer. Luo X; Wu Y; Ji M; Zhang S Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212 [TBL] [Abstract][Full Text] [Related]
13. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer. Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of serum miR-103 predicts unfavorable prognosis in patients with colorectal cancer. Wang DS; Zhong B; Zhang MS; Gao Y Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4518-4523. PubMed ID: 30058684 [TBL] [Abstract][Full Text] [Related]
15. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Matsumura T; Sugimachi K; Iinuma H; Takahashi Y; Kurashige J; Sawada G; Ueda M; Uchi R; Ueo H; Takano Y; Shinden Y; Eguchi H; Yamamoto H; Doki Y; Mori M; Ochiya T; Mimori K Br J Cancer; 2015 Jul; 113(2):275-81. PubMed ID: 26057451 [TBL] [Abstract][Full Text] [Related]
16. Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer. Nonaka R; Miyake Y; Hata T; Kagawa Y; Kato T; Osawa H; Nishimura J; Ikenaga M; Murata K; Uemura M; Okuzaki D; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M Int J Oncol; 2015 Sep; 47(3):1097-102. PubMed ID: 26134152 [TBL] [Abstract][Full Text] [Related]
17. Postoperative changes in plasma miR21-5p as a novel biomarker for colorectal cancer recurrence: A prospective study. Fukada M; Matsuhashi N; Takahashi T; Sugito N; Heishima K; Yoshida K; Akao Y Cancer Sci; 2021 Oct; 112(10):4270-4280. PubMed ID: 34270831 [TBL] [Abstract][Full Text] [Related]
18. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression. Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150 [TBL] [Abstract][Full Text] [Related]
20. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. Luo X; Stock C; Burwinkel B; Brenner H PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]